NTI Secures Option to Cannabis Strains Targeting Autism
Filed with ASX · · 5 pages · English
Neurotech International Ltd. on 6ix
Earlier from Neurotech International
- Mente receives CE Mark renewal for use with ASD Children
- Response to Appendix 4C Query
- Cancellation of Mente Device from Australian TGA Register
- Appendix 4E and Annual Report to Shareholders
- Quarterly Update & Appendix 4C
Later from Neurotech International
- Pause in Trading
- Response to ASX price query
- Neurotech Proceeds to in vitro trials after Positive Results
- Response to ASX Price and Volume Query
- Interim Results and Capital Raising
Follow Neurotech International into a list and get an email when it puts out news.
Follow Neurotech International